# Clinical Study to Assess Efficacy and Safety of Amiodarone in Treating Patients With Ebola. Virus Disease (EVD) in Sierra Leone. EASE (EMERGENCY Amiodarone Study Against Ebola)

> **NCT02307591** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **Emergency NGO Onlus**

## Conditions studied

- Ebola Virus Disease

## Interventions

- **DRUG:** Best Supportive Care
- **DRUG:** Best Supportive Care + Amiodarone

## Key facts

- **NCT ID:** NCT02307591
- **Lead sponsor:** Emergency NGO Onlus
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-12
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The Study could not be started due to an insufficient number of new EVD cases.
- **Last updated:** 2015-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02307591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02307591, "Clinical Study to Assess Efficacy and Safety of Amiodarone in Treating Patients With Ebola. Virus Disease (EVD) in Sierra Leone. EASE (EMERGENCY Amiodarone Study Against Ebola)". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02307591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*